POLE and neoplasm: The results also revealed that the TMB scores were higher in patients with POLE mutations than in WT patients (Figure 1D), suggesting that POLE mutations may lead to the production of neoantigens, which can trigger an immune response and potentially enhance the immunogenicity of the tumor.